Number of participants who withdraw due to treatment-emergent adverse events (TEAEs);Change from baseline in RR values;Change from baseline in PR values;Magnitude of abnormal urinalysis findings;Change from baseline in respiratory rate values;Magnitude of abnormal hematologic laboratory findings;Frequency of treatment-emergent infusion site reactions;Frequency of treatment-emergent serious adverse events;Frequency of treatment-emergent adverse events (TEAEs), causally related to study intervention;Change from baseline in systolic blood pressure;Frequency of treatment-emergent adverse events (TEAEs);Change from baseline in diastolic blood pressure;Change from baseline in pulse oximetry/SpO2 measurement;Change from baseline in temperature values;Change from baseline in pulse rate measurements;Frequency of abnormal hematologic laboratory findings;Frequency of abnormal chemistry values;Change from baseline in QRS values;Change from baseline in QTcF values;Change from baseline in QTc values

Number of participants who withdraw due to treatment-emergent adverse events (TEAEs);Change from baseline in RR values;Change from baseline in PR values;Magnitude of abnormal urinalysis findings;Change from baseline in respiratory rate values;Magnitude of abnormal hematologic laboratory findings;Frequency of treatment-emergent infusion site reactions;Frequency of treatment-emergent serious adverse events;Frequency of treatment-emergent adverse events (TEAEs), causally related to study intervention;Change from baseline in systolic blood pressure;Frequency of treatment-emergent adverse events (TEAEs);Change from baseline in diastolic blood pressure;Change from baseline in pulse oximetry/SpO2 measurement;Change from baseline in temperature values;Change from baseline in pulse rate measurements;Frequency of abnormal hematologic laboratory findings;Frequency of abnormal chemistry values;Change from baseline in QRS values;Change from baseline in QTcF values;Change from baseline in QTc values